Liver Neoplasms

"Liver Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Tumors or cancer of the LIVER.

Descriptor ID	D008113
MeSH Number(s)	C04.588.274.623 C06.301.623 C06.552.697
Concept/Terms	Liver Neoplasms Liver Neoplasms Neoplasms, Hepatic Neoplasms, Liver Liver Neoplasm Neoplasm, Liver Hepatic Neoplasms Hepatic Neoplasm Neoplasm, Hepatic Cancer of Liver Cancer of Liver Hepatocellular Cancer Cancers, Hepatocellular Hepatocellular Cancers Hepatic Cancer Cancer, Hepatic Cancers, Hepatic Hepatic Cancers Liver Cancer Cancer, Liver Cancers, Liver Liver Cancers Cancer of the Liver Cancer, Hepatocellular

Below are MeSH descriptors whose meaning is more general than "Liver Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Digestive System Neoplasms [C04.588.274]
Liver Neoplasms [C04.588.274.623]
Digestive System Diseases [C06]
Digestive System Neoplasms [C06.301]
Liver Neoplasms [C06.301.623]
Liver Diseases [C06.552]
Liver Neoplasms [C06.552.697]

Below are MeSH descriptors whose meaning is more specific than "Liver Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Liver Neoplasms" by people in this website by year, and whether "Liver Neoplasms" was a major or minor topic of these publications.

Bar chart showing 162 publications over 26 distinct years, with a maximum of 14 publications in 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1999	0	1	1
2001	0	3	3
2002	5	0	5
2003	2	0	2
2004	0	3	3
2005	2	1	3
2006	7	3	10
2007	8	2	10
2008	3	0	3
2009	4	1	5
2010	2	2	4
2011	5	1	6
2012	8	2	10
2013	6	1	7
2014	8	0	8
2015	3	1	4
2016	9	3	12
2017	5	1	6
2018	5	0	5
2019	10	4	14
2020	7	1	8
2021	11	1	12
2022	1	0	1
2023	10	1	11
2024	2	0	2
2025	6	1	7

Below are the most recent publications written about "Liver Neoplasms" by people in Profiles.

Alaa El-Dein M, Ali DA, Ghoneum MH. Biobran/MGN-3, Arabinoxylan Rice Bran, Ameliorates the Liver Architecture in Ehrlich Ascites Tumor-Bearing Mice as a Cotreatment with Chemotherapy. Integr Cancer Ther. 2026 Jan-Dec; 25:15347354261430853.

View in: PubMed
Gao Y, Chen W, Zarogoulidis P, Yallapu MM, Nikolic MV, Vaishnani DK, Zheng J, Nedeljkovic N, Ye K, Guo Y, Xu Q. Multiomics and experimental validation reveal theophylline's mechanism targeting IL1A/ACTB/TLR4 and identify synergistic drugs in hepatocellular carcinoma. J Pharmacol Exp Ther. 2026 Mar; 393(3):103836.

View in: PubMed
Miyatani Y, Ogawa A, Sempokuya T, Tran C, James D, Seto T, Shikuma C, Kuwada SK. Ethnic disparities in metabolic dysfunction-associated steatotic liver disease and clinical outcomes. Front Endocrinol (Lausanne). 2025; 16:1739137.

View in: PubMed
Saleem S, Sajid MS, Varghese RS, Sherif ZA, Kroemer A, Ressom HW. Phosphopeptidome Profiling of Human Plasma for Hepatocellular Carcinoma Biomarker Discovery. J Proteome Res. 2026 Feb 06; 25(2):1115-1125.

View in: PubMed
Nara A, Shimada S, Akiyama Y, Hatano M, Chino Y, Miyazawa S, Tamura H, Asano D, Ishikawa Y, Ueda H, Watanabe S, Katsuta E, Akahoshi K, Ohashi K, Tanabe M, Ban D, Tanaka S. Targeting SPP1-CD44-Hedgehog Axis Elicits Therapeutic Effects in Hepatocellular Carcinoma by Suppressing Intratumoral Fibrosis. Cancer Sci. 2026 Mar; 117(3):670-682.

View in: PubMed
Sassano M, Nalini M, Seyyedsalehi MS, Roshandel G, Poustchi H, Khoshnia M, Kamangar F, Dawsey SM, Abnet C, Malekzadeh R, Boffetta P, Etemadi A. Body size and occupational physical activity during the life course and gastrointestinal cancers. Am J Epidemiol. 2025 Dec 02; 194(12):3451-3463.

View in: PubMed
Singh A, Gupta I, Saha P, Hole A, Anthony F, Natu A, Smoot DT, Ashktorab H, Chilakapati MK, Gupta S. Raman spectroscopy for detecting gastric and liver cancer cells that entered a tolerant persistence state to survive cisplatin chemotherapy. Biochem Biophys Res Commun. 2025 11 19; 790:152891.

View in: PubMed
Singh A, Natu A, Anthony F, Muthu H, Khade B, Smoot DT, Ashktorab H, Gupta S. The synergistic action of HDAC inhibitor with cisplatin impedes survival and proliferation of drug-tolerant persister in gastric and liver cancer cells. Clin Epigenetics. 2025 Oct 08; 17(1):168.

View in: PubMed
He AR, Smith CI, Cruz-Correa M, Chakraborty R, Zhang S, Sang S, Cheng G, Hecht SS, Bazzi LA, Kocherginsky M, Benante KA, Schering T, Richmond E, Rodriguez LM, Khan SA, Chung FL. A Phase I Dose-Escalation Study of Polyphenon E in Liver Cirrhosis: Evaluation of Safety and Effect on Liver ?-OHPdG Levels. Cancer Prev Res (Phila). 2025 Oct 01; 18(10):635-646.

View in: PubMed
Brim H, Gonzales S, Deverapalli M, Laiyemo AO, Rashid M, Zafar R, Nembhard C, Ashktorab H. Advanced-stage colorectal cancer in the context of coronavirus disease-19, highlighting socioeconomic disparities and outcomes: a case report. J Med Case Rep. 2025 Sep 29; 19(1):467.

View in: PubMed

People

Explore

Similar Concepts

Top Journals